Back to Search
Start Over
3TR: a pan-European cross-disease research consortium aimed at improving personalised biological treatment of asthma and COPD.
- Source :
- The European respiratory journal, Vol. 58, no. 4, p. 2102168 [1-7] (2021)
- Publication Year :
- 2021
-
Abstract
- The 3TR (Taxonomy, Treatments, Targets and Remission) consortium is the largest IMI (Innovative Medicine Initiative) project ever started in the field of immune diseases (https://3tr-imi.eu/). 3TR is unique in bringing several medical specialties, encompassing respiratory medicine, rheumatology, neurology and gastroenterology, together, to study disease mechanisms across seven disease entities: asthma, COPD, systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, ulcerative colitis and Crohn's disease. [...]
Details
- Database :
- OAIster
- Journal :
- The European respiratory journal, Vol. 58, no. 4, p. 2102168 [1-7] (2021)
- Notes :
- English
- Publication Type :
- Electronic Resource
- Accession number :
- edsoai.on1372961816
- Document Type :
- Electronic Resource